Long‐Term Follow‐up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug‐Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

Long‐Term Follow‐up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug‐Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

BackgroundClinical outcomes reported after treatment of infrapopliteal lesions with drug‐eluting stents (DESs) have been more favorable compared with percutaneous transluminal angioplasty with a bailout bare metal stent (PTA‐BMS) through midterm follow‐up in patients with critical limb ischemia. In...

Full description

Bibliographic Details
Main Authors: Marlon I. Spreen, Jasper M. Martens, Bob Knippenberg, Lukas C. van Dijk, Jean‐Paul P. M. de Vries, Jan Albert Vos, Gert Jan de Borst, Evert‐Jan P. A. Vonken, Okker D. Bijlstra, Jan J. Wever, Randolph G. Statius van Eps, Willem P. Th. M. Mali, Hendrik van Overhagen
Format: Article
Language:English
Published: Wiley 2017-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
critical limb ischemia
drug‐eluting stent
endovascular treatment
peripheral artery disease
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.004877

Similar Items

Similar Items